Giant Cell Arteritis

2018 Update of the EULAR recommendations for the management of large vessel vasculitis
Bernhard Hellmich, Ana Agueda, Sara Monti, Frank Buttgereit, Hubert de Boysson, Elisabeth Brouwer, Rebecca Cassie, Maria C Cid, Bhaskar Dasgupta, Christian Dejaco, Gulen Hatemi, Nicole Hollinger, Alfred Mahr, Susan P Mollan, Chetan Mukhtyar, Cristina Ponte, Carlo Salvarani, Rajappa Sivakumar, Xinping Tian, Gunnar Tomasson, Carl Turesson, Wofgang Schmidt, Peter M Villiger, Richard Watts, Chris Young, Raashid Ahmed Luqmani

Annals of the Rheumatic Diseases Jul 2019, annrheumdis-2019-215672; DOI: 10.1136/annrheumdis-2019-215672
Remission maintenance after tocilizumab dose-tapering and interruption in patients with giant cell arteritis: an open-label, 18-month, prospective, pilot study
Carlotta Nannini, Laura Niccoli, Stelvio Sestini, Iashar Laghai, Angela Coppola, Fabrizio Cantini

Annals of the Rheumatic Diseases Jun 2019, annrheumdis-2019-215585; DOI: 10.1136/annrheumdis-2019-215585
Serial IL-6 measurements in patients with tocilizumab-treated large-vessel vasculitis detect infections and may predict early relapses
Christoph T Berger, Birke Rebholz-Chaves, Mike Recher, Tobias Manigold, Thomas Daikeler

Annals of the Rheumatic Diseases Jul 2019, 78 (7) 1012-1014; DOI: 10.1136/annrheumdis-2018-214704
Longitudinal versus cross-sectional IL-6 measurements in tocilizumab-treated GCA response to: ‘Analysis of IL-6 measurement in GCA patients treated with tocilizumab should consider concomitant treatment with prednisone’ by Samson et al
Christoph T Berger, Thomas Daikeler

Annals of the Rheumatic Diseases May 2019, annrheumdis-2019-215729; DOI: 10.1136/annrheumdis-2019-215729
Analysis of IL-6 measurement in patients with GCA treated with tocilizumab should consider concomitant treatment with prednisone
Maxime Samson, Bernard Bonnotte

Annals of the Rheumatic Diseases May 2019, annrheumdis-2019-215697; DOI: 10.1136/annrheumdis-2019-215697
The role of temporal artery biopsy in patients with giant-cell arteritis is debated
Sergey V Moiseev, Ilya Smitienko, Nikolay Bulanov, Pavel I Novikov

Annals of the Rheumatic Diseases Apr 2019, 78 (4) e31; DOI: 10.1136/annrheumdis-2018-213282
Response to: ‘The role of temporal artery biopsy in patients with giant cell arteritis is debated’ by Moiseev et al
Christian Dejaco, Sofia Ramiro, Christina Duftner, Wolfgang A Schmidt

Annals of the Rheumatic Diseases Apr 2019, 78 (4) e32; DOI: 10.1136/annrheumdis-2018-213284
Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis
Young Ho Lee, Gwan Gyu Song

Annals of the Rheumatic Diseases Jan 2019, 78 (1) e9; DOI: 10.1136/annrheumdis-2017-212838
Interleukin 12 and interleukin 23 play key pathogenic roles in inflammatory and proliferative pathways in giant cell arteritis
Richard Conway, Lorraine O’Neill, Geraldine M McCarthy, Conor C Murphy, Aurelie Fabre, Susan Kennedy, Douglas J Veale, Sarah M Wade, Ursula Fearon, Eamonn S Molloy

Annals of the Rheumatic Diseases Dec 2018, 77 (12) 1815-1824; DOI: 10.1136/annrheumdis-2018-213488
Response to: ‘Is the PET/CT first choice for differential diagnosis of FUO/IUO?’ by Armagan et al
Verena Schönau, Georg Schett

Annals of the Rheumatic Diseases Nov 2018, 77 (11) e83; DOI: 10.1136/annrheumdis-2017-212785

Main menu

Giant Cell Arteritis

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Giant Cell Arteritis

Pages